Sunho Biologics (HKSE:02898) Days Inventory: 0.00 (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02898 Sunho Biologics Inc HKSE:02898
11 GF Score
Price HK$6.39
! 1 Warning Sign
View Full Analysis

What is Sunho Biologics Days Inventory?

Sunho Biologics HKSE:02898 11 Days Inventory is 0.00 as of Jun. 2025. GuruFocus rates HKSE:02898 with a GF Score™ of 11/100. The stock has 1 warning sign investors should review.

Days Inventory is also known as Days Sales of Inventory (DSI). Sunho Biologics's Average Total Inventories for the six months ended in Jun. 2025 was HK$1.12 Mil. Sunho Biologics's Cost of Goods Sold for the six months ended in Jun. 2025 was HK$0.00 Mil.

The historical rank and industry rank for Sunho Biologics's Days Inventory or its related term are showing as below:

During the past 3 years, Sunho Biologics's highest Days Inventory was 4453.47. The lowest was 255.63. And the median was 2354.55.

HKSE:02898's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 180.135
* Ranked among companies with meaningful Days Inventory only.

Sunho Biologics's Days Inventory stayed the same from Jun. 2024 (0.00) to Jun. 2025 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year. Sunho Biologics's Inventory Turnover for the six months ended in Jun. 2025 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Sunho Biologics  (HKSE:02898) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sunho Biologics's Inventory Turnover for the six months ended in Jun. 2025 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sunho Biologics's Inventory to Revenue for the six months ended in Jun. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Sunho Biologics Days Inventory Related Terms


Sunho Biologics Days Inventory Historical Data

* Premium members only.

The historical data trend for Sunho Biologics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunho Biologics Days Inventory Chart

Sunho Biologics Annual Data
Trend Dec22 Dec23 Dec24
Days Inventory
255.63 4,453.47 0.00

Sunho Biologics Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Days Inventory Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

HKSE:02898 vs VRTX, REGN, ALNY: Days Inventory Comparison

For the Biotechnology subindustry, Sunho Biologics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunho Biologics Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunho Biologics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Sunho Biologics's Days Inventory falls into.


HKSE:02898
11GF Score
Sunho Biologics Inc HKSE:02898
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunho Biologics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sunho Biologics's Days Inventory for the fiscal year that ended in Dec. 2024 is calculated as

Days Inventory (A: Dec. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2023 ) + Total Inventories (A: Dec. 2024 )) / count ) / Cost of Goods Sold (A: Dec. 2024 )*Days in Period
=( (0.895 + 1.04) / 2 ) / 0*365
=0.9675 / 0*365
=N/A

Sunho Biologics's Days Inventory for the quarter that ended in Jun. 2025 is calculated as:

Days Inventory (Q: Jun. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2024 ) + Total Inventories (Q: Jun. 2025 )) / count ) / Cost of Goods Sold (Q: Jun. 2025 )*Days in Period
=( (1.04 + 1.203) / 2 ) / 0*365 / 2
=1.1215 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 0.00 mean?
Sunho Biologics (HKSE:02898) has a Days Inventory of 0.00 as of Jun. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sunho Biologics and its competitors. Over the past decade, Sunho Biologics' Days Inventory has ranged from 255.63 to 4,453.47.
Is Sunho Biologics' Days Inventory too high?
Sunho Biologics' current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 255.63 to a high of 4,453.47. Overall, Sunho Biologics has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Sunho Biologics' Days Inventory compare to VRTX and REGN?
Sunho Biologics' Days Inventory of 0.00 can be compared against companies in the Biotechnology industry. The industry median Days Inventory is 180.14. Historically, Sunho Biologics' own Days Inventory has ranged from 255.63 to 4,453.47 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 180.14, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sunho Biologics and its competitors. For the Biotechnology industry, the median Days Inventory is 180.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunho Biologics's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunho Biologics stock overvalued right now?
Sunho Biologics (HKSE:02898) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Sunho Biologics' overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sunho Biologics (HKSE:02898), the current Days Inventory is 0.00 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunho Biologics Business Description

Address No. 198 Peninsula Middle Road, Dipu Street, Room 302, Building 3, Anji County, Zhejiang Province, Huzhou, CHN
Sunho Biologics Inc is a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of biologics for the treatment of cancers and autoimmune diseases. It has three Core Products, IAH0968, IAP0971, and IAE0972, all of which are developed in-house. IAH0968 is an antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced monoclonal antibody (mAb), and the company has initiated Phase II clinical trials for biliary tract carcinoma (BTC) and colorectal cancer (CRC). IAP0971 and IAE0972 are both immunocytokines and It has completed Phase I clinical trials for advanced solid tumors including non-small cell lung cancer (NSCLC) and CRC.
11GF Score

Get the complete analysis for HKSE:02898

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.39
Price